June 3, 2020 / 8:40 PM / a month ago

BRIEF-Inovio Pharma Says Filed Complaint Seeking To Compel Vgxi Inc & Geneone Life Scienc To Facilitate Transfer Of Manufacturing Methods

June 3 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO PHARMA - FILED COMPLAINT SEEKING TO COMPEL VGXI, INC & GENEONE LIFE SCIENC TO FACILITATE TRANSFER OF MANUFACTURING METHODS, USING VGXI’S TECHNOLOGY

* INOVIO PHARMA - TECHNOLOGY TRANSFER AS PERMITTED UNDER AGREEMENT TO ALLOW FOR LARGE-SCALE MANUFACTURE OF CO’S VACCINE CANDIDATE INO-4800 AGAINST COVID-19

* INOVIO PHARMACEUTICALS INC - HAS A GOAL OF PRODUCING ONE MILLION DOSES OF INO-4800 BY END OF 2020

* INOVIO PHARMACEUTICALS - VGXI INFORMED CO IT DID NOT HAVE CAPACITY TO MANUFACTURE CO’S FULL ORDER OF DNA PLASMIDS ON REQUESTED TIMELINE

* INOVIO PHARMA - VGXI INFORMED CO IT WOULD NOT BE ABLE TO MANUFACTURE PLASMIDS FOR COMMERCIAL SALE OF INO-4800, IF IT WERE TO BE APPROVED FOR SALE

* INOVIO PHARMACEUTICALS - BEGAN DISCUSSIONS WITH OTHER THIRD-PARTY CONTRACT MANUFACTURERS, AS PERMITTED BY SUPPLY AGREEMENT

* INOVIO PHARMACEUTICALS - INTENDS TO ENGAGE ADDITIONAL CONTRACT MANUFACTURERS FOR PRODUCTION OF INO-4800 Source text: (bit.ly/2Xx7Je6) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below